Sarah Hollingsworth "Holly" Lisanby, M.D., Director of the Division of Translational Research, will join Arizona State University as Founding Dean of the new ASU School of Medicine. Since joining NIMH in 2015, Lisanby led the merger to create the Division of Translational Research, overseeing significant research funding and fostering collaboration. She launched programs that spanned various research domains, contributed to The BRAIN Initiative, and directed the Noninvasive Neuromodulation Unit, focusing on developing treatments for depression and autism spectrum disorder.
Sarah Hollingsworth "Holly" Lisanby, M.D., Director of the Division of Translational Research (DTR), will depart NIMH to join Arizona State University (ASU) as Founding Dean of the new ASU School of Medicine and Advanced Medical Engineering.
Under Dr. Lisanby’s leadership, NIMH's Division of Translational Research launched several new programs to advance an integrative research portfolio that bridges a range of research domains, including computational psychiatry, social neuroscience, statistical methods, neuromodulation, neurotherapeutics, and translational genomics.
Dr. Lisanby has also held significant roles in The BRAIN Initiative, as co-lead of a team focused on large-scale neural recording and modulation devices.
Dr. Lisanby’s key accomplishments include pioneering magnetic seizure therapy as a rapid-acting treatment for depression.
Collection
[
|
...
]